SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-202512
Filing Date
2019-07-25
Accepted
2019-07-25 16:05:03
Documents
7
Period of Report
2019-08-23
Effectiveness Date
2019-07-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d782329ddef14a.htm DEF 14A 580465
2 GRAPHIC g782329g03a10.jpg GRAPHIC 56721
3 GRAPHIC g782329g33n26.jpg GRAPHIC 63615
4 GRAPHIC g782329g57o07.jpg GRAPHIC 59488
5 GRAPHIC g782329g68a23.jpg GRAPHIC 47282
6 GRAPHIC g782329page1new.jpg GRAPHIC 1849
7 GRAPHIC g782329page2.jpg GRAPHIC 1869
  Complete submission text file 0001193125-19-202512.txt   900381
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37929 | Film No.: 19974461
SIC: 2834 Pharmaceutical Preparations